Treatment of systemic lupus erythematosus

Systemic lupus erythematosus should be suspected in individuals with one or more classic symptoms. Diagnosis is made clinically and supported by serology Reducing sun exposure is central to the management of lupus Hydroxychloroquine is first-line treatment unless contraindicated and is useful in alm...

Descripción completa

Detalles Bibliográficos
Autores principales: McKeon, Kathryn P, Jiang, Simon H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358053/
https://www.ncbi.nlm.nih.gov/pubmed/32675909
http://dx.doi.org/10.18773/austprescr.2020.022
_version_ 1783558779692908544
author McKeon, Kathryn P
Jiang, Simon H
author_facet McKeon, Kathryn P
Jiang, Simon H
author_sort McKeon, Kathryn P
collection PubMed
description Systemic lupus erythematosus should be suspected in individuals with one or more classic symptoms. Diagnosis is made clinically and supported by serology Reducing sun exposure is central to the management of lupus Hydroxychloroquine is first-line treatment unless contraindicated and is useful in almost all manifestations of lupus. Other treatments are titrated against type and severity of organ involvement Monoclonal antibodies have a limited role in the management of lupus
format Online
Article
Text
id pubmed-7358053
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-73580532020-07-15 Treatment of systemic lupus erythematosus McKeon, Kathryn P Jiang, Simon H Aust Prescr Article Systemic lupus erythematosus should be suspected in individuals with one or more classic symptoms. Diagnosis is made clinically and supported by serology Reducing sun exposure is central to the management of lupus Hydroxychloroquine is first-line treatment unless contraindicated and is useful in almost all manifestations of lupus. Other treatments are titrated against type and severity of organ involvement Monoclonal antibodies have a limited role in the management of lupus NPS MedicineWise 2020-06-02 2020-06 /pmc/articles/PMC7358053/ /pubmed/32675909 http://dx.doi.org/10.18773/austprescr.2020.022 Text en (c) NPS MedicineWise 2020 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Article
McKeon, Kathryn P
Jiang, Simon H
Treatment of systemic lupus erythematosus
title Treatment of systemic lupus erythematosus
title_full Treatment of systemic lupus erythematosus
title_fullStr Treatment of systemic lupus erythematosus
title_full_unstemmed Treatment of systemic lupus erythematosus
title_short Treatment of systemic lupus erythematosus
title_sort treatment of systemic lupus erythematosus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358053/
https://www.ncbi.nlm.nih.gov/pubmed/32675909
http://dx.doi.org/10.18773/austprescr.2020.022
work_keys_str_mv AT mckeonkathrynp treatmentofsystemiclupuserythematosus
AT jiangsimonh treatmentofsystemiclupuserythematosus

Ejemplares similares